High Intensity Focused Ultrasound for Radiorecurrent Prostate Cancer: A North American Clinical Trial

Abstract

Whole gland high intensity focused ultrasound appears reasonably safe and effective to treat radiorecurrent prostate cancer. The rate of complications, which are potentially severe, was acceptable, especially considering the advanced, refractory nature of the disease and the limited treatment options.